Mizuho downgraded CoreWeave (CRWV) to Neutral from Outperform with a price target of $150, up from $70. The firm believes the company’s acquisition of Core Scientific (CORZ) brings additional financing flexibility and expanded internal expertise, which builds upon an “already powerful partnership.” However, Mizuho also acknowledges that CoreWeave’s “extremely high volatile” presents risks to both the upside and downside. It views the stock as fairly valued at current levels with risks around customer concentration.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRWV:
- CoreWeave downgraded to Hold from Buy at Stifel
- CoreWeave’s $9 Billion Acquisition of Core Scientific: Strategic Expansion with Cautious Hold Rating
- CoreWeave’s Strategic Acquisition: Balancing Growth Potential with Integration Challenges and Market Uncertainties
- M&A News: CoreWeave (CRWV) Stock Falls Despite $9B Core Scientific Acquisition—Will the Deal Pay Off?
- Core Scientific downgraded to Neutral from Buy at BTIG